In the IER mailed to shareholders, the IE marginally raised his/her preferred price to 20.8 from 20.7 so I don't think it's a 0.1 cent bidding war at play here, merely Pfizer hoping to sway enough no voters to change their votes. All IMO only.
RAP Price at posting:
18.0¢ Sentiment: Hold Disclosure: Held